Literature DB >> 16433757

Liver ischemia contributes to early islet failure following intraportal transplantation: benefits of liver ischemic-preconditioning.

D Yin1, J W Ding, J Shen, L Ma, M Hara, A S Chong.   

Abstract

Early graft failure following intraportal islet transplantation (IPIT) represents a major obstacle for successful islet transplantation. Here, we examined the role of islet emboli in the induction of early graft failure and utilized a strategy of ischemic-preconditioning (IP) to prevent early islet destruction in a model of syngeneic IPIT in STZ-induced diabetic mice. Numerous focal areas of liver necrosis associated with the islet emboli were observed within 24 h post-IPIT. Pro-inflammatory cytokines, IL-1beta and IL-6, were significantly increased 3 h after IPIT, while TNF-alpha was elevated for up to 5 days post-IPIT. Caspase-3 and terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling positive cells were observed in the transplanted islets trapped in areas of necrotic liver at 3 h and 1 day post-IPIT. Hyperglycemia was corrected immediately following IPIT of 200 islets, but recurrence of hyperglycemia was observed within 14 days associated with a poor response to glucose challenge. IP, a procedure of pre-exposure of the liver to transient ischemia and reperfusion, protected the liver from embolism-induced ischemic injury and prevented early islet graft failure. These data suggest that islet embolism in the portal vein is a major cause of functional loss following IPIT that can be prevented by liver IP.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16433757     DOI: 10.1111/j.1600-6143.2005.01157.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  32 in total

1.  Factors affecting islet graft embolization in the liver of diabetic mice.

Authors:  Naoaki Sakata; Andre Obenaus; Nathaniel Chan; John Mace; Richard Chinnock; Eba Hathout
Journal:  Islets       Date:  2009-07-01       Impact factor: 2.694

Review 2.  Enhancing clinical islet transplantation through tissue engineering strategies.

Authors:  Jaime A Giraldo; Jessica D Weaver; Cherie L Stabler
Journal:  J Diabetes Sci Technol       Date:  2010-09-01

Review 3.  Cellular therapies for type 1 diabetes.

Authors:  D D Lee; E Grossman; A S Chong
Journal:  Horm Metab Res       Date:  2008-02       Impact factor: 2.936

Review 4.  Alternative transplantation sites for pancreatic islet grafts.

Authors:  Elisa Cantarelli; Lorenzo Piemonti
Journal:  Curr Diab Rep       Date:  2011-10       Impact factor: 4.810

5.  Improvement of islet function in a bioartificial pancreas by enhanced oxygen supply and growth hormone releasing hormone agonist.

Authors:  Barbara Ludwig; Avi Rotem; Janine Schmid; Gordon C Weir; Clark K Colton; Mathias D Brendel; Tova Neufeld; Norman L Block; Karina Yavriyants; Anja Steffen; Stefan Ludwig; Triantafyllos Chavakis; Andreas Reichel; Dimitri Azarov; Baruch Zimermann; Shiri Maimon; Mariya Balyura; Tania Rozenshtein; Noa Shabtay; Pnina Vardi; Konstantin Bloch; Paul de Vos; Andrew V Schally; Stefan R Bornstein; Uriel Barkai
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-05       Impact factor: 11.205

6.  Hyperbaric oxygen therapy improves early posttransplant islet function.

Authors:  Naoaki Sakata; Nathaniel K Chan; Robert P Ostrowski; John Chrisler; Pete Hayes; Sonny Kim; Andre Obenaus; John H Zhang; Eba Hathout
Journal:  Pediatr Diabetes       Date:  2010-11       Impact factor: 4.866

Review 7.  Islet cell transplantation.

Authors:  P Srinivasan; G C Huang; S A Amiel; N D Heaton
Journal:  Postgrad Med J       Date:  2007-04       Impact factor: 2.401

8.  Thrombosis and inflammation in intraportal islet transplantation: a review of pathophysiology and emerging therapeutics.

Authors:  John T Wilson; Elliot L Chaikof
Journal:  J Diabetes Sci Technol       Date:  2008-09

9.  Thrombomodulin improves early outcomes after intraportal islet transplantation.

Authors:  W Cui; J T Wilson; J Wen; J Angsana; Z Qu; C A Haller; E L Chaikof
Journal:  Am J Transplant       Date:  2009-05-20       Impact factor: 8.086

10.  Kidney Versus Islet Allograft Survival After Induction of Mixed Chimerism With Combined Donor Bone Marrow Transplantation.

Authors:  Tetsu Oura; Dicken S C Ko; Svjetlan Boskovic; John J O'Neil; Vaja Chipashvili; Maria Koulmanda; Kiyohiko Hotta; Kento Kawai; Ognjenka Nadazdin; R Neal Smith; A B Cosimi; Tatsuo Kawai
Journal:  Cell Transplant       Date:  2015-09-02       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.